Conflicting results exist on the analysis of relationship between clinicopathological parameters and Gal-3 expression (Jiang et al., 2014; Matsuda et al., 2008) and the limited reports of Gal-9 in HCC in previous literatures. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.